Functional gastrointestinal disorders. How to manage them without medication

María Del C Toca1, Silvina Balbarrey2, Cinthia Bastianelli3

  • 1Consultorios Médicos Pediátricos, Ramos Mejía, Argentina. mtoca@intramed.net.

Insights

This update reviews functional gastrointestinal disorders (FGIDs) in infants, focusing on managing common conditions like colic and constipation. It aims to provide evidence-based strategies to reduce infant discomfort and parental anxiety.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Infant Health

Background:

  • Functional gastrointestinal disorders (FGIDs) present significant discomfort in infants and distress for parents.
  • Diagnosis relies on clinical criteria and ruling out organic causes through case history and physical examination.

Purpose of the Study:

  • To update management strategies for common FGIDs in infants under one year.
  • Focuses on colic, regurgitation, dyschezia, and constipation.
  • Aims to prevent unnecessary diagnostic tests and treatments.

Main Methods:

  • Review of current pathophysiological insights into infant FGIDs.
  • Clinical diagnostic criteria for FGIDs.
  • Evidence-based management approaches.

Main Results:

  • FGIDs lack structural or biochemical abnormalities.
  • Effective management strategies for colic, regurgitation, dyschezia, and constipation are presented.
  • Emphasis on avoiding over-testing and over-medication.

Conclusions:

  • Updated management strategies for infant FGIDs are crucial.
  • Understanding pathophysiology aids in appropriate treatment.
  • This guidance helps clinicians manage common FGIDs effectively.

Related Concept Videos

Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
276
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
173
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
140
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
295
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
397
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
269